152 related articles for article (PubMed ID: 2993611)
1. Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60).
Yamada S; Yamamoto K; Naito H; Suzuki T; Ohmori M; Takayama H; Shiina Y; Miyaura C; Tanaka H; Abe E
J Med Chem; 1985 Sep; 28(9):1148-53. PubMed ID: 2993611
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the differentiating action of 25-hydroxyvitamin D3 endoperoxides in human myeloid leukemia cells (HL-60).
Shiina Y; Miyaura C; Tanaka H; Abe E; Yamada S; Yamamoto K; Ino E; Takayama H; Matsunaga I; Nishii Y
J Med Chem; 1985 Sep; 28(9):1153-8. PubMed ID: 2993612
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of vitamin D3 derivatives in inducing differentiation of HL-60 human promyelocytic leukemia cells.
Yoshida M; Ishizuka S; Hoshi A
J Pharmacobiodyn; 1984 Dec; 7(12):962-8. PubMed ID: 6099852
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells.
Shiina Y; Abe E; Miyaura C; Tanaka H; Yamada S; Ohmori M; Nakayama K; Takayama H; Matsunaga I; Nishii Y; DeLuca HF; Suda T
Arch Biochem Biophys; 1983 Jan; 220(1):90-4. PubMed ID: 6572492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of novel vitamin D analogues: 24,24-difluoro-25-hydroxy-26,27-dimethylvitamin D3 and 24,24-difluoro-1 alpha,25-dihydroxy-26,27-dimethylvitamin D3.
Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
J Med Chem; 1990 Feb; 33(2):480-90. PubMed ID: 2153815
[TBL] [Abstract][Full Text] [Related]
7. Synthetic studies of vitamin D analogues. XVII. Synthesis and differentiation-inducing activity of 1 alpha,24-dihydroxy-22-oxavitamin D3 analogues and their 20(R)-epimers.
Kubodera N; Watanabe H; Miyamoto K; Matsumoto M; Matsuoka S; Kawanishi T
Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1659-63. PubMed ID: 8221979
[TBL] [Abstract][Full Text] [Related]
8. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
9. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
Wilhelm F; Mayer E; Norman AW
Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biologic activity, and protein binding characteristics of a new vitamin D analog, 22-hydroxyvitamin D3.
Gill HS; Londowski JM; Corradino R; Kumar R
J Steroid Biochem; 1987 Aug; 28(2):147-53. PubMed ID: 3041108
[TBL] [Abstract][Full Text] [Related]
11. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor.
Addo JK; Swamy N; Ray R
Steroids; 1999 Apr; 64(4):273-82. PubMed ID: 10399884
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and biological activity of 25-hydroxy-26,27-dimethylvitamin D3 and 1,25-dihydroxy-26,27-dimethylvitamin D3: highly potent novel analogs of vitamin D3.
Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
J Steroid Biochem; 1988 Aug; 31(2):147-60. PubMed ID: 3404985
[TBL] [Abstract][Full Text] [Related]
13. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
14. 23-Keto-25-hydroxyvitamin D3: a vitamin D3 metabolite with high affinity for the 1,25-dihydroxyvitamin D specific cytosol receptor.
Horst RL; Reinhardt TA; Pramanik BC; Napoli JL
Biochemistry; 1983 Jan; 22(2):245-50. PubMed ID: 6297543
[TBL] [Abstract][Full Text] [Related]
15. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
16. 24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro.
Ostrem VK; Tanaka Y; Prahl J; DeLuca HF; Ikekawa N
Proc Natl Acad Sci U S A; 1987 May; 84(9):2610-4. PubMed ID: 3033654
[TBL] [Abstract][Full Text] [Related]
17. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia.
Abe J; Morikawa M; Miyamoto K; Kaiho S; Fukushima M; Miyaura C; Abe E; Suda T; Nishii Y
FEBS Lett; 1987 Dec; 226(1):58-62. PubMed ID: 2826255
[TBL] [Abstract][Full Text] [Related]
18. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
Sokoloski JA; Shyam K; Sartorelli AC
Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity.
Li W; Chen J; Janjetovic Z; Kim TK; Sweatman T; Lu Y; Zjawiony J; Tuckey RC; Miller D; Slominski A
Steroids; 2010 Dec; 75(12):926-35. PubMed ID: 20542050
[TBL] [Abstract][Full Text] [Related]
20. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
Kuribayashi T; Tanaka H; Abe E; Suda T
Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
